TrialThe New England journal of medicine2020
Pembrolizumab for Early Triple-Negative Breast Cancer.
Peter Schmid et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,865 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialThe New England journal of medicine2020
Peter Schmid et al.PubMed ↗Publisher ↗
No numbers read from the abstract.